Evaluating blood flow reconstruction for treating intracranial aneurysms
Analysis of the Therapeutic Effect of Blood Flow Reconstruction in the Treatment of Intracranial Dissection Aneurysm of Vertebral Artery
Qilu Hospital of Shandong University · NCT06134557
This study looks at different ways to treat patients with a specific type of brain aneurysm to see which methods work best for improving their health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 30 Years to 80 Years |
| Sex | All |
| Sponsor | Qilu Hospital of Shandong University (other) |
| Locations | 1 site (Jinan) |
| Trial ID | NCT06134557 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with intracranial vertebral artery dissecting aneurysms (IVADA) who underwent endovascular blood reconstructive treatment at Qilu Hospital of Shandong University from December 2011 to December 2022. It aims to assess the effectiveness of various endovascular techniques, including conventional stents and flow diverters, while recording patient demographics, clinical presentations, and treatment outcomes. The study evaluates the optimal treatment strategy based on neurological conditions, comorbidities, and the anatomical features of the aneurysm. Data collected will help inform future treatment approaches for IVADA patients.
Who should consider this trial
Good fit: Ideal candidates include patients with asymptomatic or subarachnoid hemorrhage symptoms related to IVADA confirmed by angiography.
Not a fit: Patients with SAH due to trauma or other cerebrovascular diseases, or those with extracranial vertebral artery involvement, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment outcomes and reduce complications for patients with IVADA.
How similar studies have performed: Other studies have shown success with endovascular techniques for treating similar conditions, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with asymptomatic or SAH symptoms of intracranial hypertension 2. After a preliminary diagnosis of cerebrovascular CTA or MRA, DSA angiography confirmed IVADA 3. IVADA involves intracranial segment of vertebral artery (V4 ) Exclusion Criteria: * : Patients with SAH caused by trauma or other cerebrovascular diseases 2: IVADA involves the extracranial vertebral artery 3: Vertebrobasilar artery tortuosity and dilatation
Where this trial is running
Jinan
- Qilu Hospital of Shandong University — Jinan, China (RECRUITING)
Study contacts
- Principal investigator: Maogui li — Medical Ethics Committee of Qilu Hospital of Shandong University
- Study coordinator: Tongfu Zhang
- Email: 532323616@qq.com
- Phone: 0086-18054566265
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Intracranial Aneurysm